121 related articles for article (PubMed ID: 4879594)
1. [The effect of diazoxide on glucagon-induced insulin secretion].
Brech WJ; Kaess H; Schlierf G; Rohs M
Klin Wochenschr; 1968 Apr; 46(8):449-50. PubMed ID: 4879594
[No Abstract] [Full Text] [Related]
2. Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors.
Buchanan KD; Vance JE; Williams RH
Diabetes; 1969 Jun; 18(6):381-6. PubMed ID: 4892443
[No Abstract] [Full Text] [Related]
3. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
4. Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH; Mahler RF; Hales CN
Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
[TBL] [Abstract][Full Text] [Related]
5. Diazoxide and the secretion of insulin.
Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
[No Abstract] [Full Text] [Related]
6. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
7. Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia.
Kuzuya T; Kanazawa Y
Diabetologia; 1969 Aug; 5(4):248-57. PubMed ID: 4902720
[No Abstract] [Full Text] [Related]
8. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R
Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834
[TBL] [Abstract][Full Text] [Related]
9. [Modification of insulin-secretion, induced by glucose, of the isolation-perfused rat pancreas using tolbutamide, glucosamine, diazoxide, glucagon and endogenous insulin].
Bierwolf B; Blech W
Acta Biol Med Ger; 1976; 35(5):583-95. PubMed ID: 983609
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the inhibitory effects of diphenylhydantoin and diazoxide upon insulin secretion from the isolated perfused pancreas.
Levin SR; Grodsky GM; Hagura R; Smith D
Diabetes; 1972 Aug; 21(8):856-62. PubMed ID: 4558084
[No Abstract] [Full Text] [Related]
11. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
[No Abstract] [Full Text] [Related]
12. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
13. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Frerichs H; Gerber R; Creutzfeldt W
Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
[No Abstract] [Full Text] [Related]
14. [Morphology and histochemistry of insulin secretion].
Creutzfelt W
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
[No Abstract] [Full Text] [Related]
15. The control of glucagon secretion.
Nutr Rev; 1972 Aug; 30(8):188-92. PubMed ID: 4558744
[No Abstract] [Full Text] [Related]
16. The morphological substrate of the inhibition of insulin secretion by diazoxide.
Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
[No Abstract] [Full Text] [Related]
17. Comparative effects of LN 5330 and diazoxide on insulin release and 86Rb+ permeability in perifused rat islets of Langerhans.
Petit P; Blayac JP; Manteghetti M; Loubatières-Mariani MM
Biochem Pharmacol; 1991 Jul; 42(4):787-91. PubMed ID: 1867635
[TBL] [Abstract][Full Text] [Related]
18. Effect of thiazides upon insulin secretion in vitro.
Malaisse W; Malaisse-Legae F
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):235-9. PubMed ID: 4868989
[No Abstract] [Full Text] [Related]
19. Control of insulin secretion by imidazolines in rat pancreatic islets.
Brown CA; Morgan NG
Biochem Soc Trans; 1993 May; 21(2):109S. PubMed ID: 8359366
[No Abstract] [Full Text] [Related]
20. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
Song SH; Rhodes CJ; Veldhuis JD; Butler PC
Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
